The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability
- PMID: 19366855
- DOI: 10.1210/jc.2008-1980
The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability
Abstract
Context: RET is a tyrosine kinase transmembrane receptor expressed in two main alternative isoforms: RET9 and RET51. RET transduces a positive signal leading to survival, differentiation, or migration in the presence of its ligand glial cell line-derived neurotrophic factor, whereas in its absence a proapoptotic fragment that initiates a negative signaling for apoptosis is generated. The signal transduction mechanisms leading to apoptosis are still unclear.
Objective: To shed light on the mechanisms of RET-induced apoptosis, we searched for novel interactors of RET51.
Design: The "split ubiquitin yeast two-hybrid system" was used with RET51 as bait against a human brain expression library.
Results: We identified aryl hydrocarbon receptor-interacting protein (AIP), a cochaperone recently found mutated in pituitary adenoma patients, as a novel interactor of RET. We showed that RET interacts specifically with AIP both in mammalian cell lines and in vivo in the pituitary gland, regardless of the presence of pituitary adenoma-specific mutations. AIP and RET genes were sequenced in 28 pituitary adenoma, but no relevant mutations were found. In addition, we identified the proapoptotic domain of RET as responsible for the interaction with AIP. Finally, we demonstrated that the AIP-RET interaction does not require RET kinase activity or kinase-dependent signal transduction and that it prevents the formation of the AIP-survivin complex.
Conclusions: The identification of the AIP-RET complex represents a starting point to study key cellular processes involved in RET-induced apoptosis.
Similar articles
-
No evidence of RET germline mutations in familial pituitary adenoma.J Mol Endocrinol. 2010 Dec 21;46(1):1-8. doi: 10.1677/JME-10-0052. Print 2011 Feb. J Mol Endocrinol. 2010. PMID: 20956458
-
RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.Oncogene. 2021 Nov;40(45):6354-6368. doi: 10.1038/s41388-021-02009-8. Epub 2021 Sep 29. Oncogene. 2021. PMID: 34588620 Free PMC article.
-
AIP gene and familial isolated pituitary adenomas.Mol Cell Endocrinol. 2010 Sep 15;326(1-2):71-9. doi: 10.1016/j.mce.2010.05.001. Epub 2010 May 8. Mol Cell Endocrinol. 2010. PMID: 20457215 Review.
-
Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants.Horm Metab Res. 2017 Apr;49(4):286-295. doi: 10.1055/s-0043-104700. Epub 2017 Apr 20. Horm Metab Res. 2017. PMID: 28427099 Review.
-
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.Endocr Relat Cancer. 2011 Jun 8;18(3):347-56. doi: 10.1530/ERC-11-0059. Print 2011 Jun. Endocr Relat Cancer. 2011. PMID: 21450940
Cited by
-
Familial isolated pituitary adenomas: an emerging clinical entity.J Endocrinol Invest. 2012 Dec;35(11):1003-14. doi: 10.1007/BF03346742. J Endocrinol Invest. 2012. PMID: 23310926 Review.
-
The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.Endocrine. 2014 Aug;46(3):387-96. doi: 10.1007/s12020-013-0125-6. Epub 2013 Dec 24. Endocrine. 2014. PMID: 24366639 Review.
-
Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma.ISRN Oncol. 2011;2011:732452. doi: 10.5402/2011/732452. Epub 2011 Apr 18. ISRN Oncol. 2011. PMID: 22091429 Free PMC article.
-
Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31. Endocr Rev. 2013. PMID: 23371967 Free PMC article. Review.
-
In vivo bioassay to test the pathogenicity of missense human AIP variants.J Med Genet. 2018 Aug;55(8):522-529. doi: 10.1136/jmedgenet-2017-105191. Epub 2018 Apr 9. J Med Genet. 2018. PMID: 29632148 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous